Skip to main content
Arthritis Research & Therapy logoLink to Arthritis Research & Therapy
. 2012 Apr 10;14(2):401. doi: 10.1186/ar3790

Correction: FoxP3 and Bcl-xL cooperatively promote regulatory T cell persistence and prevention of arthritis development

Rizwanul Haque 1, Fengyang Lei 1, Xiaofang Xiong 1, Yuzhang Wu 2, Jianxun Song 1,2,
PMCID: PMC3446442

Correction

Following publication of our recent article [1], it was brought to our attention that there are errors in Figure 5b and Supplementary Table 2.

The corrected Figure and table are given here as Figure 1 (a corrected version of Figure 5b [1]) and Table 1 (a corrected version of Supplementary Table 2 [1]).

Figure 1.

Figure 1

Adoptive cell transfer of FoxP3- and Bcl-xL-transduced regulatory T cells suppresses collagen-induced arthritis (CIA).

Table 1.

Summary of the mouse arthritis scores of the three experiments

Score

Days (post immunization) Mig Mig-FoxP3 Mig-Bcl-xL-2A-FoxP3
10 0, 0, 0 0, 0, 0 0, 0, 0
20 0, 0, 0 0, 0, 0 0, 0, 0
22 1.00, 0, 0.83 0, 0, 0 0, 0, 0
24 2.00, 0, 1.67 0, 0, 0 0, 0, 0
28 2.67, 1.67, 2.67 0.50, 0, 0.50 0, 0, 0
30 3.30, 2.83, 3.30 0.50, 0, 1.17 0, 0, 0
32 3.67, 3.00, 3.50 0.50, 1.17, 1.50 0, 0, 0
34 3.83, 3.00, 3.67 1.00, 1.67, 1.50 0.83, 0, 0
38 3.83, 3.00, 3.67 1.17, 1.67, 1.83 0.83, 0.50, 0
40 3.83, 3.30, 3.67 1.50, 1.67, 2.00 1.00, 0.50, 0
42 3.83, 3.30, 3.83 1.50, 2.00, 2.17 1.17, 0.50, 0.50
48 3.83, 3.50, 3.83 2.00, 2.00, 2.67 1.50, 0.83, 0.83
50 3.83, 3.50, 3.83 2.00, 2.17, 2.67 1.67, 1.00, 1.00
60 3.83, 3.50, 3.83 2.00, 2.40, 3.00 1.67, 1.00, 1.17

Naive CD4+ T cells from DBA/1J mice were stimulated with anti-CD3 plus anti-CD28 antibodies. On days 2 and 3, the cells were transduced with retroviral constructs: vector (Mig), FoxP3 (Mig-FoxP3), or FoxP3 with Bcl-xL (Mig-Bcl-xL-2A-FoxP3). On day 6, green fl uorescent protein-positive (GFP+) T cells were sorted and prepared for adoptive cell transfer. CIA was induced in male DBA/1J mice (>4 months old) by one (day 0) intradermal immunization in the base of the tail with 100 μg of bovine type II collagen in complete Freund's adjuvant, containing 5 mg/mL killed Mycobacterium tuberculosis (H37Ra). On day 15 after the immunization, the mice received transduced GFP+ cells (2.5 × 106 per mouse, six mice per group). In the following days, the arthritis clinical score was evaluated by examining the paws and using a 4-point scale: 0, normal paw; 1, minimal swelling or redness; 2, redness and swelling involving the entire forepaw; 3, redness and swelling involving the entire limp; 4, joint deformity or ankylosis or both. Values are the mean ± standard error of the mean of data obtained in three experiments, and in each experiment, six mice per group were used.

See related research by Haque et al., http://arthritis-research.com/content/12/2/R66

Contributor Information

Rizwanul Haque, Email: sdtono@gmail.com.

Fengyang Lei, Email: sdtohe@gmail.com.

Xiaofang Xiong, Email: ally_shone@hotmail.com.

Yuzhang Wu, Email: yuxhangwu@rocketmail.com.

Jianxun Song, Email: jus35@psu.edu.

References

  1. Haque R, Lei F, Xiong X, Wu Y, Song J. FoxP3 and Bcl-xL cooperatively promote regulatory T cell persistence and prevention of arthritis development. Arthritis Res Ther. 2010;12:R66. doi: 10.1186/ar2983. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Arthritis Research & Therapy are provided here courtesy of BMC

RESOURCES